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Abstract
Background: Primary diffuse leptomeningeal gliomatosis is a rare neoplasm confined to the
meninges without evidence of primary tumor in the brain or spinal cord parenchyma.
Cerebrospinal fluid diversion via ventriculoperitoneal shunt may be used as a therapeutic modality.
Herein, we describe the first report of cytologic findings of a case of this neoplasm with shunt-
related peritoneal metastasis.
Case presentation: A 19-year-old male presented with a 6-month history of severe headaches.
He had bilateral papilledema on physical exam. Cerebrospinal fluid examination was negative. Four
months later a ventriculoperitoneal shunt was placed. Shortly thereafter, he was diagnosed with
primary diffuse leptomeningeal gliomatosis based on the biopsy of an intradural extramedullary
lesion adjacent to the lumbar spinal cord at a referral cancer center. The histology featured an
infiltrating growth pattern of pleomorphic astrocytes with diffuse positivity for glial fibrillary acidic
protein. A couple of months later he presented at our institution with ascites and an anterior
peritoneal mass. Repeat cerebrospinal fluid cytology and fine needle aspiration of the mass
confirmed disseminated gliomatosis. Cytologic characteristics included clusters of anaplastic cells
of variable size, high nuclear to cytoplasm ratio and scant to moderate cytoplasm. Occasional single
bizarre multinucleated cells were seen with eccentric "partial wreath-like" nuclei, clumped
chromatin and prominent nucleoli. Patient expired 13 months after initial presentation.
Conclusion: Disseminated primary diffuse leptomeningeal gliomatosis should be considered in the
differential diagnosis of chronic aseptic meningitis and in the presence of a peritoneal tumor in
patients with ventriculoperitoneal shunts. Immunocytochemistry may be of diagnostic value.
Introduction
Primary diffuse leptomeningeal gliomatosis (PDLG) is a
rare uniformly fatal neoplastic condition. It is character-
ized by widespread infiltration of the meninges by tumor
thought to arise from heterotopic glial cell nests, without
evidence of primary tumor within the brain or spinal cord
parenchyma [1]. Glial heterotopia is defined as nests or
linear arrays of glioneuronal tissue in the meninges. While
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their pathogenesis remains debatable, such heterotopic
nests have been noted in the subarachnoid space in about
1% of unselected autopsies [2]. The incidence is substan-
tially higher in patients with congenital anomalies, partic-
ularly those of the central nervous system [2,3].
Neoplastic transformation of extramedullary heterotopic
glial tissue is a rare event, usually diagnosed at autopsy.
One of the earliest reports of this entity was in 1936 by
Bailey [4]. Since then, fewer than two dozen cases overall,
and fewer than ten cases predominantly affecting the
meninges around the spinal cord have been reported in
the English language literature [1].
Patients with PDLG most often present with symptoms
and signs of intracranial hypertension, such as headache
and papilledema. Examination of the cerebrospinal fluid
(CSF) characteristically shows raised opening pressure,
elevated protein concentration and lymphocyte pleocyto-
sis. Diagnosis is often delayed mainly because of the non-
specific nature of the symptoms and CSF findings, such
that empirical antituberculous therapy is frequently tried
in patients with PDLG [1,5]. There appears to be no cure,
however, variable clinical and radiologic remissions last-
ing up to 4 years from presentation have been achieved
utilizing aggressive chemotherapeutic and radiation regi-
mens [1,6,7]. Cytologic examination of CSF in PDLG is
most often negative. One series reported only 1 of 8 cases
of PDLG having "atypical cells" on CSF cytology, without
further elaboration of cytologic findings [8]. This is in
contrast to a positive antemortem CSF cytologic diagnosis
in 8 out of 12 patients with secondary meningeal spread
from intracranial malignant glioma [9].
To reduce the intracranial pressure, some patients
undergo a CSF diversion procedure in the form of ven-
triculo-peritoneal (VP) or alternate route shunting [5,6].
Peritoneal tumor dissemination by way of VP shunt is a
known complication in patients with different primary
central nervous system (CNS) tumors, most often germi-
nomas [10,11]. According to our review of the literature,
this complication has not been previously reported in
PDLG.
Herein we describe the cytologic features of CSF and fine
needle aspiration (FNA) of PDLG with VP shunt-related
peritoneal spread.
Case Report
A 19 year old college freshman presented, in January of
2004, with a 6 month history of severe recurring global
headaches. He had no past medical or travel history. Phys-
ical examination was notable for bilateral papilledema.
His workup included magnetic resonance imaging (MRI)
of the brain and intracranial vessels, which initially did
not reveal any abnormalities. Initial examination of the
CSF revealed an opening pressure of 50 cm H2O (normal:
10–20 cm), protein of 778 mg/dL (normal: 15–45 mg/
dL), glucose of 44 mg/dL (normal: >45 mg/dL), an abso-
lute WBC count of 24/mm3 with 55% lymphocytes and
45% macrophages. A full microbiology workup was nega-
tive for organisms. The CSF was negative by polymerase
chain reaction (PCR) for enteroviruses and West Nile
virus. Flow cytometry showed no evidence of lymphoma
or leukemia. Cytologic examination of the CSF was nega-
tive for malignant cells, showing predominantly reactive
monocytes. The patient was initially managed sympto-
matically with analgesics and diuretics. By May of 2004,
he developed cranial nerve palsies necessitating place-
ment of a VP shunt. The patient sought a medical second
opinion at another institution, where a diagnostic biopsy
was obtained of an intradural extramedullary lesion at
T12/cauda equina via vertebral laminectomy.
The biopsy showed an infiltrating growth pattern of pleo-
morphic astrocytes. The nuclei were hyperchromatic with
irregular borders. Blood vessels were numerous. Dense,
wavy collagen bands were noted throughout the tumor,
and seemed particularly apparent in the vicinity of blood
vessels (Figure 1A). Necrosis and psammoma bodies were
absent. The neoplastic cells had variable amounts of fibril-
lary cytoplasm which was diffusely positive for glial fibril-
lary acidic protein (GFAP) (DakoCytomation, Carpinteria,
CA, 1:3000 dil; Figure 1B). A diagnosis of glial neoplasm
consistent with leptomeningeal gliomatosis was made.
Subsequently, the patient returned for care at our institu-
tion. At this time, MRI showed peripheral contrast
enhancement of the meninges surrounding the entire spi-
nal cord (Figure 2A) as well as prominent thickening and
enhancement of the cauda equina, consistent with diffuse
leptomeningeal disease. Brain MRI study showed only
subtle leptomeningeal and subarachnoid spread, without
evidence of a primary tumor. He received aggressive
craniospinal axis radiation and temozolomide chemo-
therapy which resulted in clinical improvement for a
period of about two months. By August of 2004 the
patient developed bilateral lower extremity paraplegia
and recurrent seizures. Five months later, he developed
massive ascites and an anterior peritoneal mass (Figure
2B). A computed tomography (CT)-guided FNA of the
peritoneal mass was performed. The FNA specimen was
processed as air-dried Diff-Quik (DQ) stained and alco-
hol-fixed Papanicolaou (Pap) stained direct smears, one
ThinPrep (TP) slide and a cell block. A diagnosis of VP
shunt-related peritoneal spread of PDLG was made.
DQ-stained smears showed pleomorphic malignant cells
in poorly formed, somewhat cohesive clusters with hap-
hazard cellular arrangement. The nuclei were hyperchro-
matic with great variation in size. Cytoplasmic borders
were indistinct (Figure 3). The TP showed scattered singleCytoJournal 2005, 2:16 http://www.cytojournal.com/content/2/1/16
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bizarre, very large multinucleated neoplastic cells with
"partial wreath-like" or "horse shoe" nuclear configura-
tion, coarse chromatin clumping, prominent nucleoli,
and fibrillary cytoplasmic tails (Figure 4A). Clusters or
nests of smaller, mononuclear neoplastic cells were also
seen featuring high nuclear to cytoplasm ratio, scant
homogeneous cytoplasm, occasional nuclear clefting and
more even chromatin distribution (Figure 4B). Scattered
cytoplasmic GFAP positivity was present in the cell block
material from ascites collected 3 days prior to the FNA.
Core biopsy of the peritoneal mass was confirmatory.
A repeat CSF specimen was processed as two Cytospin
slides, one stained with DQ and one with Pap. It showed
a cytomorphology similar to that of the peritoneal mass
FNA (Figures 5A and 5B).
The patient continued to deteriorate clinically. In addition
to the non-improving neurologic status, he developed
bowel obstruction which was unresponsive to palliative
pelvic radiation and peritoneal infusion of phosphorus
(P32) radioisotope. He expired in early February 2005, 13
A. Biopsy of an intradural extramedullary lesion at T12/ cauda equina, showing highly pleomorphic cells with a hint of  fibrillary cytoplasm growing in an infiltrating fashion (H&E,  ×100) Figure 1
A. Biopsy of an intradural extramedullary lesion at T12/
cauda equina, showing highly pleomorphic cells with a hint of 
fibrillary cytoplasm growing in an infiltrating fashion (H&E, 
×100). B. Diffuse cytoplasmic staining of tumor cells with 
antibody for GFAP (GFAP, ×200).
A. Postcontrast sagittal T1-weighted MR image of the cervi- cal spine shows diffuse leptomeningeal enhancement along  the surface of the spinal cord Figure 2
A. Postcontrast sagittal T1-weighted MR image of the cervi-
cal spine shows diffuse leptomeningeal enhancement along 
the surface of the spinal cord. B. Axial contrast-enhanced 
CT image through the abdomen demonstrates extensive 
ascites and an enhancing midline mass (arrows) adjacent to 
the shunt catheter (arrowhead).
CT-guided FNA of anterior peritoneal mass, showing a  somewhat cohesive large cluster of highly pleomorphic cells  (Diff-Quik, ×200) Figure 3
CT-guided FNA of anterior peritoneal mass, showing a 
somewhat cohesive large cluster of highly pleomorphic cells 
(Diff-Quik, ×200).CytoJournal 2005, 2:16 http://www.cytojournal.com/content/2/1/16
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months after initial presentation. An autopsy was
declined.
Discussion
Primary diffuse leptomeningeal gliomatosis (PDLG) is a
rare neoplastic disorder limited to the meninges, in the
absence of primary tumor within the brain or spinal cord
parenchyma [1]. The diagnosis is most often made at
autopsy, mainly because of lack of specific clinical, radio-
logic and laboratory diagnostic criteria, and the
progressive natural history of the disease [1,5,8,10]. As
such, appropriate management of affected patients is
often delayed [1,5]. Despite rare encouraging reports of
clinical improvement after aggressive radiation and chem-
otherapy [6,7], the disease is fatal in the majority of cases
[1,5,6,8]. The survival depends, in part upon the World
Health Organization (WHO) differentiation grade of
tumor, complicating lesions (e.g. infarcts), and site of
tumor [1].
The case presented in this report is unique in several
respects. It describes an exceedingly uncommon disorder,
PDLG, with peritoneal seeding as a result of symptomatic
treatment (VP shunt). While this complication is known
to occur in several different types of primary CNS tumors
[10,11], such a clinical course has not been previously
described in PDLG. This patient's tumor appeared poorly
differentiated, befitting WHO grade III or IV. Such high
tumor grade was likely a key factor determining aggressive
tumor behavior, and also the relative ease with which it
was recognized in various cytologic specimen prepara-
tions described above. A confirmatory piece of evidence in
support of the final diagnosis was demonstration of
GFAP-staining cells in ascitic fluid and core biopsy mate-
rial of the peritoneal mass.
Immunocytochemistry has been advocated as a useful
adjunct test in addition to routine CSF cytology in differ-
entiating chronic aseptic meningitis from leptomeningeal
carcinomatosis or gliomatosis especially in clinically sug-
gestive cytologically negative cases [12]. It seems far
fetched to suggest an evidence-based approach of indis-
criminate GFAP immunocytochemistry in addition to the
routine cytologic CSF examination. Nevertheless, the case
presented here serves to remind us of the need to remain
vigilant in complete review of patient information, forth-
coming in communication with clinicians and other spe-
cialists, and diligent in formulation of differential
diagnosis in each case. Only such an approach will offer
patients standard-of-care treatments, and allow for
improvements in those standards.
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